BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37163306)

  • 1. The HDAC2/YY1/c-Myc signaling axis regulates lung cancer cell migration and proliferation.
    Ali A; Ali A; Devi HS; Daddam JR; Sarwar R; Badrealam FK
    Environ Toxicol; 2023 Aug; 38(8):1989-2001. PubMed ID: 37163306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.
    Tang W; Zhou W; Xiang L; Wu X; Zhang P; Wang J; Liu G; Zhang W; Peng Y; Huang X; Cai J; Bai Y; Bai L; Zhu W; Gu H; Xiong J; Ye C; Li A; Liu S; Wang J
    Nat Commun; 2019 Feb; 10(1):663. PubMed ID: 30737378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.
    Li W; Ye K; Li X; Liu X; Peng M; Chen F; Xiong W; Wang Y; Zhu L
    J Exp Clin Cancer Res; 2022 Aug; 41(1):250. PubMed ID: 35974388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC01089, suppressed by YY1, inhibits lung cancer progression by targeting miR-301b-3p/HPDG axis.
    Yang R; Liu Z; Cao H; Shi Y
    Cell Biol Toxicol; 2022 Dec; 38(6):1063-1077. PubMed ID: 34561789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1.
    Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
    Cancer Biomark; 2017 Dec; 21(1):221-228. PubMed ID: 29060934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors inhibit lung adenocarcinoma metastasis via HDAC2/YY1 mediated downregulation of Cdh1.
    Wang D; Yang Y; Cao Y; Meng M; Wang X; Zhang Z; Fu W; Duan S; Tang L
    Sci Rep; 2023 Jul; 13(1):12069. PubMed ID: 37495623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc-mediated
    Li M; Liu Y; Wei Y; Wu C; Meng H; Niu W; Zhou Y; Wang H; Wen Q; Fan S; Li Z; Li X; Zhou J; Cao K; Xiong W; Zeng Z; Li X; Qiu Y; Li G; Zhou M
    J Biol Chem; 2019 Apr; 294(15):6172-6187. PubMed ID: 30718276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR‑29a suppresses IL‑13‑induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells.
    Zhang Y; He S; Mei R; Kang Y; Duan J; Wei R; Xiang C; Wu Y; Lu X; Cai Z; Xiong L
    Oncol Rep; 2018 Jun; 39(6):2613-2623. PubMed ID: 29620222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
    Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
    Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wogonin has multiple anti-cancer effects by regulating c-Myc/SKP2/Fbw7α and HDAC1/HDAC2 pathways and inducing apoptosis in human lung adenocarcinoma cell line A549.
    Chen XM; Bai Y; Zhong YJ; Xie XL; Long HW; Yang YY; Wu SG; Jia Q; Wang XH
    PLoS One; 2013; 8(11):e79201. PubMed ID: 24265759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of lncRNA CRNDE attenuates nonsmall-cell lung cancer progression by mediating the miR-455-3p/HDAC2 axis.
    Li N; Chen XJ; Zeng YH; Zeng LP; Hu K; Chen LJ
    Kaohsiung J Med Sci; 2022 Aug; 38(8):749-760. PubMed ID: 35611803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.
    Yang J; Fan L; Liao X; Cui G; Hu H
    Bioengineered; 2021 Dec; 12(2):9377-9389. PubMed ID: 34818994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.
    Xu P; Xiao H; Yang Q; Hu R; Jiang L; Bi R; Jiang X; Wang L; Mei J; Ding F; Huang J
    Exp Mol Med; 2020 Jan; 52(1):41-55. PubMed ID: 31956270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ampelopsin induces apoptosis by regulating multiple c-Myc/S-phase kinase-associated protein 2/F-box and WD repeat-containing protein 7/histone deacetylase 2 pathways in human lung adenocarcinoma cells.
    Chen XM; Xie XB; Zhao Q; Wang F; Bai Y; Yin JQ; Jiang H; Xie XL; Jia Q; Huang G
    Mol Med Rep; 2015 Jan; 11(1):105-12. PubMed ID: 25333250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression.
    Xia B; Li H; Yang S; Liu T; Lou G
    Tumour Biol; 2016 Jul; 37(7):9157-67. PubMed ID: 26768613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YY1-mediated overexpression of long noncoding RNA MCM3AP-AS1 accelerates angiogenesis and progression in lung cancer by targeting miR-340-5p/KPNA4 axis.
    Li X; Yu M; Yang C
    J Cell Biochem; 2020 Mar; 121(3):2258-2267. PubMed ID: 31693222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects and mechanism of microRNA‑218 against lung cancer.
    Chen Y; Yang JL; Xue ZZ; Cai QC; Hou C; Li HJ; Zhao LX; Zhang Y; Gao CW; Cong L; Wang TZ; Chen DM; Li GS; Luo SQ; Yao Q; Yang CJ; Zhu QS; Cao CH
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1.
    Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
    DNA Cell Biol; 2017 Nov; 36(11):947-958. PubMed ID: 28972861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-147b influences vascular smooth muscle cell proliferation and migration via targeting YY1 and modulating Wnt/β-catenin activities.
    Yue Y; Lv W; Zhang L; Kang W
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):905-913. PubMed ID: 30060075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC2 promotes the migration and invasion of non-small cell lung cancer cells via upregulation of fibronectin.
    Li L; Mei DT; Zeng Y
    Biomed Pharmacother; 2016 Dec; 84():284-290. PubMed ID: 27665474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.